Revolutionize STI Diagnosis with Premier PCR Testing

The Cost of Inadequate Diagnosis

Inadequate or delayed diagnosis of STIs can have serious consequences. It increases the risk of complications, promotes further transmission of infections, and leads to more advanced disease states. The lack of sensitive testing methods hampers the accurate identification of pathogens, especially in low concentration cases. This not only impedes effective treatment but also fuels the growing concern of antibiotic resistance. The societal stigma surrounding STIs further exacerbates the problem, discouraging patients from seeking timely help.

STI Panel

CoreBioLabs uses advanced molecular identification techniques, with the QuantStudio 12 Flex by ThermoFisher®. We proudly offer an option for in-house Antibiotic Susceptibility Testing. After positive culture growth, our BD Phoenix® system provides antimicrobial concentrations for detection of emerging resistance.

Pathogens + Antibiotic Resistance Genes

  • Chlamydia trachomatis
  • Gonorrhea/ Neisseria gonorrhoeae
  • Haemophilus ducreyi
  • Herpes virus 1
  • Herpes virus 2
  • Human papillomavirus 16
  • Human papillomavirus 18
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Treponema pallidum
  • Trichomonas vaginalis
  • Ureaplasma parvum
  • Ureaplasma urealyticum


Resistance Markers:

  • Carbapenems
  • ESBL
  • Fosfomycin
  • Macrolide
  • Quinolone
  • Sulfonamide/ Trimethopri
  • Tetracycline
  • Vancomycin
  • AmpC
  • Methicillin

CoreBioLabs’ PCR Testing: Revolutionizing STI Diagnostics

CoreBioLabs rises to the challenge of STI diagnostics with our advanced PCR testing services. We’ve crafted a solution that not only meets but exceeds the demands of modern STI testing:

  • Early and Accurate Detection: Our PCR tests excel in detecting the smallest traces of genetic material, ensuring the early detection of STIs. This level of sensitivity is crucial for timely intervention.
  • Rapid Results, Better Outcomes: With quick and precise results, our PCR testing enables prompt treatment, reducing the risk of transmission and complications associated with delayed diagnosis.
  • Comprehensive Screening for Co-Infections: Our cutting-edge multiplex PCR techniques can simultaneously identify multiple STIs in a single test. This capability is vital in addressing co-infections efficiently.
  • Encouraging Screening through Non-Invasive Methods: By utilizing non-invasive samples such as urine or swabs, our PCR testing helps reduce the stigma associated with STI testing, encouraging more people to get tested.
  • Tailored Treatment Strategies: Accurate identification of pathogens through our tests guides personalized treatment plans, addressing the challenge of antibiotic resistance head-on.
  • Community Health Impact: Our proactive screening approach in high-risk populations is a pivotal step in enhancing community health outcomes through early detection and treatment.

CoreBioLabs’ PCR Testing:
Precision, Speed, and Compassion in STI Detection

At CoreBioLabs, we offer a groundbreaking solution with our PCR testing services for STIs, tailored to overcome these diagnostic challenges:

  1. Exceptional Sensitivity and Specificity: Our PCR testing detects even the smallest quantities of genetic material, ensuring early detection of STIs, including in asymptomatic cases.
  2. Rapid and Reliable Results: Delivering quick and accurate diagnoses, our PCR testing facilitates prompt treatment initiation, crucial in preventing transmission and complications.
  3. Comprehensive Co-Infection Detection: Our advanced multiplex PCR techniques can identify multiple STIs in a single test, addressing the challenge of co-infections effectively.
  4. Reducing Stigma with Non-Invasive Testing: The use of simple urine samples or non-invasive swabs in PCR testing encourages more individuals to undergo STI screening.
  5. Personalized Treatment Guidance: Accurate pathogen identification enables tailored treatment regimens, crucial in the era of antibiotic resistance.

Proactive Screening in High-risk Populations: Regular PCR screening in high-risk groups aids in early detection and treatment, enhancing community health outcomes.

CoreBioLabs’ PCR Testing: Elevating STI Diagnostics for Better Health Outcomes

Join us at CoreBioLabs in transforming the landscape of STI diagnosis and treatment. Our PCR testing services bring precision, sensitivity, and rapid results to the forefront, paving the way for improved patient care and public health. Choose CoreBioLabs for a future where every STI diagnosis is timely, accurate, and treated effectively.

Please Fill In the Form
to Download

Contact Us Today.